CJC-1295 / Ipamorelin is a two-peptide combination that prompts your pituitary to produce more growth hormone on its own. Growth hormone levels drop roughly 15% per decade after age 30, and the effects show up as slower recovery, stubborn body fat, lower energy, and less muscle.
BEST FOR
Adults with age-related growth hormone decline and performance or body composition goals
METHOD
Subcutaneous injection
FREQUENCY
Daily or several times per week
All information regarding products and services on this site are for educational purposes only. Dynamis Online is not a pharmacy and does not manufacture, distribute, or ship any medications discussed on this site. Our licensed medical professionals work with you to develop a personalized treatment plan that fits your unique health goals. All products and medications are manufactured and distributed by independent, third-party vendor pharmacies and are routinely inspected by both state and federal agencies for safety and efficacy.
These peptides raise your growth hormone and IGF-1 levels, which signals your muscles to grow and recover more efficiently. Patients who combine this protocol with consistent training typically see meaningful gains in lean muscle within three to six months.
Higher growth hormone levels push your body to burn stored fat for energy, especially around the midsection. This effect builds gradually, making CJC-1295 / Ipamorelin one of the more effective peptide options for improving body composition over time.
Growth hormone is released mainly during deep sleep, and CJC-1295 / Ipamorelin strengthens that cycle. Most patients notice faster recovery between workouts and noticeably better sleep within the first two to four weeks.
Growth hormone supports collagen production and skin elasticity. These changes take months, not weeks, but they’re real and meaningful for adults who want to stay healthy and functional long-term.
CJC-1295 is a peptide that prompts your pituitary to release more growth hormone, by extending and strengthening the signal your body already sends naturally. Ipamorelin does the same thing through a different mechanism. Together, they produce a stronger, more sustained growth hormone output than either peptide would on its own.
Unlike direct HGH therapy, CJC-1295 / Ipamorelin works with your body’s own production rather than replacing it, which most providers consider a safer long-term approach. Clinical evidence shows this combination produces measurable increases in growth hormone and IGF-1, the markers your provider tracks to confirm the protocol is working.
We start with baseline labs including growth hormone, IGF-1, and a full hormone panel to get a clear picture of where you’re starting. This tells your board-certified provider whether CJC-1295 / Ipamorelin is the right fit and what dose makes sense for your goals.
Your provider sets your dosing based on your lab results, symptoms, and goals. Starting doses typically range from 100 to 300 mcg of each peptide per injection, calibrated to your IGF-1 response rather than a fixed formula.
You receive injection training and direct access to your dedicated health coach. Questions about protocol timing, dose adjustments, or anything you are experiencing get answered within four hours across all channels.
Follow-up labs keep tabs on your growth hormone and IGF-1 levels. Your provider adjusts the protocol as your results come in, keeping you in the therapeutic range as your goals evolve. Most patients notice real improvements in how they feel within three months.
Direct HGH therapy adds synthetic growth hormone to your body from an outside source. CJC-1295 / Ipamorelin works differently: it signals your body to produce more on its own, which keeps the release pattern more natural. Most providers consider this a lower-risk approach for long-term use. Both are available at Dynamis, and your provider will help you choose based on your labs and goals.
Most patients notice sleep quality improvements and faster recovery within two to four weeks. Meaningful body composition changes, including increases in lean mass and reductions in body fat, typically appear at three to six months. The protocol builds over time, so patients who stay consistent for six months or more see the most significant results.
The most common side effects are mild and tend to fade in the first few weeks: some water retention, a flushing sensation near the injection site, increased appetite, and occasional headaches. Your provider monitors your hormone levels throughout treatment to keep your response in the therapeutic range and catch any issues early.
Most protocols start at 100 to 300 mcg of each peptide per injection, taken once or twice a day as a small under-the-skin injection. Your exact dose depends on your IGF-1 levels, goals, and provider assessment. Dynamis providers calibrate your protocol to your labs, not a standard number.
Tesamorelin is a similar peptide that was developed specifically to reduce abdominal fat in people with a condition called lipodystrophy. It has a narrower use case. CJC-1295 / Ipamorelin covers more ground: muscle growth, fat loss, recovery, sleep quality, and general anti-aging support. Your provider will recommend whichever fits your situation best.
